|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.70 HKD | -1.27% |
|
-5.25% | -1.05% |
| 08:57am | Hansoh Pharma Gets China Nod for Trial of Tumor Drug | MT |
| 05-13 | Hansoh pharmaceutical says HS-10541 tablets obtain clinical trial approval from China's NMPA | RE |
Upcoming dividends: Hansoh Pharmaceutical Group Company Limited
| 03/07/2026 | Ex-dividend date | HK$0.2 Payment date: 24/07/2026 | 05:00 |
EPS & Dividend: Hansoh Pharmaceutical Group Company Limited
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 0.0732 | 0.1 | 0.2129 | 0.3363 | 0.4316 | 0.3557 | 0.3834 | 0.4239 |
| Rate of return | 0.47% | 0.76% | 1.49% | 2.07% | 1.33% | 1.13% | 1.22% | 1.35% |
| EPS 2 | 0.44 | 0.44 | 0.55 | 0.73 | 0.93 | 0.9851 | 1.085 | 1.234 |
| Distribution rate | 16.6% | 22.7% | 38.7% | 46.1% | 46.4% | 36.1% | 35.3% | 34.4% |
| Reference price 2 | 15.48 | 13.13 | 14.31 | 16.24 | 32.42 | 31.36 | 31.36 | 31.36 |
| Nbr of stocks (in thousands) | 5,922,350 | 5,920,764 | 5,923,735 | 5,934,335 | 6,053,955 | 6,062,955 | - | - |
| Announcement Date | 29/03/22 | 27/03/23 | 26/03/24 | 21/03/25 | 29/03/26 | - | - | - |
Past dividends: Hansoh Pharmaceutical Group Company Limited
| 22/09/2025 | Ex-dividend date - 0.2316 HKD | 05:00 |
| 03/07/2025 | Ex-dividend date - 0.1353 HKD | 05:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.13% | 1.22% | 31.83x | 4.83x | 9.17x | |
| 0.67% | 0.74% | 29.8x | 17.79x | 10.81x | |
| 2.32% | 2.42% | 24.63x | 6.2x | 5.68x | |
| 3.29% | 3.47% | 25.42x | -2779.26x | 6.28x | |
| 3.13% | 3.21% | 16.92x | 6.21x | 4.24x | |
| 1.79% | 1.89% | 23.43x | 5.43x | 4.86x | |
| 3.01% | 3.15% | 20.6x | 6.19x | 5.55x | |
| 2.94% | 3.05% | 50.61x | 5.76x | 4.74x | |
| 3.73% | 3.64% | 13.54x | 5.87x | 4.96x | |
| 3% | 3.17% | 21.88x | 16.31x | 5.9x | |
| Average | 2.5% | 2.6% | 25.87x | -270.47x | 6.22x | |
| Weighted average by Cap. | 2.24% | 2.34% | 26.28x | -289.80x | 6.80x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition